仅用于工业应用或科学研究，不可用于人类或动物的临床诊断或治疗，非药用. Eldelumab （BMS-936557） is a humanised anti-CXCL10 （IP-10） monoclonal antibody （IgG1 type）. Eldelumab selectively binds to CXCL10 and blocks CXCL10-induced calcium flux and cell migration. Eldelumab can be used in studies of autoimmune and auto-inflammatory diseases such as rheumatoid arthritis, ulcerative colitis and crohn's disease